BGI invites scientists around the world to join in translational research collaborations in disease areas such as those listed below. We offer free-of-charge Whole Genome Sequencing for up to 50% of the samples for accepted projects.
BGI will perform the sample QC, library construction and sequencing and deliver sequencing data from the BGISEQ sequencing platform.
We ask participating collaborators to share the knowledge gained from these collaborations through co-authorship of scientific publication, share resulting IP and contribute to study design and coordination.
We expect that patients who have enrolled in project cohorts have given consent to allow sharing of sequencing and phenotypic data. Patient consent groups and/or data use limitations for proposed samples should be listed in the project application.
How to Apply
Please submit the information via Join GDP or via email to P_GDP@bgi.com. All proposals will be reviewed by BGI. Proposals which support the Genome Decode Program’s mission will be reviewed and approved within 1 month of receipt of the application.
About the Genome Decode Program
Over 10,000 Whole Genome Sequencing samples have been processed to date with BGI’s BGISEQ DNA Nanoball sequencing technology and several peer reviewed publications have resulted. The Genome Decode Program was initiated by BGI to invite the global research community to experience this new sequencing technology while gaining a better understanding of the link between gene and disease.